NPY messenger RNA is increased in medial hypothalamus of anorectic tumor-bearing rats

Regulatory Peptides

Volumn 75-76, Issue , 1998, Pages 347-353

  Chance, William T ^a,b   Sheriff, Sulaiman ^b   Kasckow, John W ^a,b   Regmi, Ajit ^b   Balasubramaniam, A ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Anorexia; Cancer; Corticosterone; CRF; mRNA; NPY; Transcription

Indexed keywords

CORTICOTROPIN; MESSENGER RNA; NEUROPEPTIDE Y;

ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; BRAIN REGION; CACHEXIA; CONTROLLED STUDY; HYPOTHALAMUS; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; TUMOR MODEL;

ANIMALS; ANOREXIA; CORTICOTROPIN-RELEASING HORMONE; HYPOTHALAMUS, MIDDLE; MALE; NEUROPEPTIDE Y; RATS; RNA, MESSENGER; RNA, NEOPLASM; SARCOMA, EXPERIMENTAL; TIME FACTORS;

EID: 0032566851     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(98)00087-1     Document Type: Article

References (50)

1. Morrison S.D. Control of food intake in cancer cachexia: a challenge and a tool. Physiol. Behav. 17:1976;705-714.
2. Warren S. The immediate causes of death in cancer. Am. J. Med. Sci. 184:1932;610-615.
3. DeWys W.D., Begg C., Lavin P.T. Pronostic effect of weight loss prior to chemotherapy in cancer patients. Am. J. Med. 69:1980;491-497.
4. Lanzotti V.J., Thomas D.R., Boyle L.E., Smith T.L., Gehan E.A., Samuels M.L. Survival with inoperable lung cancer: an integration of prognostic variables based on simple clinical criteria. Cancer. 39:1977;303-313.
5. Gold J. Cancer cachexia and gluconeogenesis. Ann. New York Acad. Sci. 230:1974;103-110.
6. Theologides A. Pathogenesis of cachexia in cancer: a review and hypothesis. Cancer. 29:1974;484-488.
7. Morrison S.D. Origins of anorexia in neoplastic disease. Am. J. Clin. Nutr. 31:1978;1104-1107.
8. Bernstein I.L. Learned food aversions in the progression of cancer and its treatment. Ann. New York Acad. Sci. 443:1985;365-380.
9. Von Meyenfeldt M., Chance W.T., Fischer J.E. Correlation of changes in brain indoleamine metabolism with onset of anorexia in rats. Am. J. Surg. 143:1982;133-138.
10. Plata-Salaman C.R. Anorexia during acute and chronic disease. Nutrition. 12:1996;69-76.
11. Chance W.T., Fischer J.E. Some basic observations concerning experimental cancer anorexia. Nutrition. 12:1996;556-557.
12. Moldawer L., Sherry B., Lowry S.F., Cerami A. Endogenous cachectin/tumor necrosis factor-alpha production contributes to experimental cancer-associated cachexia. Cancer Surv. 8:1989;853-859.
13. Yamamura M., Modlin R.L., Ohmen J.D., Moy R.L. Local expression of antiinflammatory cytokines in cancer. J. Clin. Invest. 91:1993;1005-1010.
14. Chance W.T., von Meyenfeldt M., Fischer J.E. Serotonin depletion by 5,7-dihydroxytryptamine or para-chloroamphetamine does not affect cancer anorexia. Pharmacol. Biochem. Behav. 18:1983;115-121.
15. Chance W.T., van Lammeren F.M., Fischer J.E. Feeding elicited by cholinergic and adrenergic hypothalamic stimulation of anorectic tumor-bearing rats. Pharmacol. Biochem. Behav. 31:1988;209-213.
16. Chance W.T., van Lammeren F.M., Chen M.H.et al. Plasma and brain cholecystokinin levels in cancer anorexia. J. Surg. Res. 36:1984;490-498.
17. Chance W.T., Ramo J., Sheriff S., Zhang F.S., Fischer J.E. Reduction of neuropeptide Y (NPY)-induced feeding in tumor-bearing rats. Ann. New York Acad. Sci. 611:1990;497-499.
18. Chance W.T., Balasubramaniam A., Sheriff S., Fischer J.E. Possible role of neuropeptide Y in experimental cancer anorexia. Adv. Exp. Med. Biol. 354:1994;185-201.
19. McCarthy H.D., McKibbin P.E., Perkins A.V., Linton E.A., Williams G. Alterations in hypothalamic NPY and CRF in anorexic tumor-bearing rats. Am. J. Physiol. 264:1993;E638-E643.
20. Clark J.T., Kalra P.S., Crowley W.R., Kalra S.P. Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology. 115:1984;427-429.
21. Stanley B.G., Leibowitz S.F. Neuropeptide Y: Stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci. 35:1984;2635-2642.
22. Krahn D.D., Gosnell B.A., Lrvine A.S., Morley J.E. Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res. 443:1988;63-69.
23. Heinrichs S.C., Menzaghi F., Pich E.M., Hauger R.L., Koob G.F. Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y. Brain Res. 611:1993;18-24.
24. Liposits Z., Sievers L., Paull W.K. Neuropeptide-Y and ACTH-immunoreactive innervation of corticotropin releasing factor (CRF)-synthesizing neurons in the hypothalamus of the rat. Histochemistry. 88:1988;227-234.
25. Erickson J.C., Clegg K.E., Palmiter R.D. Sensitivity of leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature. 381:1996;415-421.
26. Erickson J.C., Hollopeter G., Palmiter R.D. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science. 274:1996;1704-1707.
27. Hulsey M.G., Pless C.M., White B.D., Martin R.J. ICV administration of anti-NPY antisense oligonucleotide: effects on feeding behavior, body weight, peptide content and peptide release. Regul. Pept. 59:1995;207-214.
28. Hanson E.S., Levin N., Dallman M.F. Elevated corticosterone is not required for the rapid induction of neuropeptide Y gene expression by an overnight fast. Endocrinology. 138:1997;1041-1047.
29. Kasckow J.W., Regmi A., Gill P.S., Parkes D.G., Geracioti T.D. Regulation of corticotropin-releasing factor (CRF) messenger ribonucleic acid and CRF peptide in the amygdala: Studies in primary amygdalar cultures. Endocrinology. 138:1997;4774-4782.
30. Balasubramaniam A., McFadden D.W., Rudnicki M.et al. Radioimmunoassay to determine postprandial changes in plasma neuropeptide Y levels in awake dogs. Neuropeptides. 14:1989;209-212.
31. Chance W.T., Balasubramaniam A., Dayal R., Brown J., Fischer J.E. Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumor-bearing rats. Life Sci. 54:1994;1869-1874.
32. Chance W.T., Balasubramaniam A., Fischer J.E. Neuropeptide Y and the development of cancer anorexia. Ann. Surg. 221:1995;579-589.
33. Chance W.T., Balasubramaniam A., Borchers M., Fischer J.E. Refractory hypothalamic adenylate cyclase in anorectic tumor-bearing rats: Implications for NPY-induced feeding. Brain Res. 691:1995;180-184.
34. Lerchen R.A., Yum D.-Y., Krajcik R., Minth-Worby C.A. Transcriptional vs. posttranscriptional control of neuropeptide Y gene expression. Endocrinology. 136:1995;833-841.
35. Kanzaki M., Fujisawa M., Okuda Y., Okada H., Arakawa S., Kamidono S. Expression and regulation of neuropeptide Y messenger ribonucleicacid in cultured immature rat Leydig and Sertoli cells. Endocrinology. 137:1996;1249-1257.
36. Heinrichs S.C., Cole B.J., Pich M., Menzaghi F., Koob G.F., Hauger R.L. Brain corticotropin-releasing factor attenuates feeding induced by neuropeptide Y or tail-pinch stress. Peptides. 13:1992;879-884.
37. Wahlestedt C., Skagerberg G., Ekman R., Heilig R., Sundler F., Hakanson R. Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat. Brain Res. 417:1987;33-38.
38. Harfstrand A., Eneroth P., Agnati L., Fuxe K. Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines. Regul. Pept. 17:1987;167-179.
39. Akabayashi A., Watanabe Y., Wahlestedt C., McEwen B.S., Paez X., Leibowitz S.F. Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomized rats. Brain Res. 665:1994;201-212.
40. Ponsalle P., Srivastava L.S., Uht R.M., White J.D. Glucorticoids are required for food deprivation-induced increases in hypothalamic neuropeptide Y expression. J. Neuroendocrinol. 4:1993;585-591.
41. Stanley B.G., Lanthier D., Chin A.S., Leibowitz S.F. Suppression of neuropeptide Y-elicited eating by adrenalectomy or hypophysectomy: reversal with corticosterone. Brain Res. 501:1989;32-36.
42. Jensen P.B., Blume N.B., Mikkelsen J.D.et al. Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA in the hypothalamic arcuate nucleus. J. Clin. Invest. 101:1998;503-510.
43. Stephens T.W., Basinski M., Bristow P.K.et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature. 377:1995;530-532.
44. Chance W.T., Sheriff S., Dayal R., Moore J., Balasubramaniam A., Fischer J.E. Possible role of leptin in cancer anorexia. Adv. Exp. Med. Biol. 422:1997;230.
45. Schwartz M.W., Sipols A.J., Marks J.L.et al. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology. 130:1992;3608-3616.
46. Chance W.T., Muggia-Sullam M., Chen M.H., Murphy R.F., Fischer J.E. Reversal of tumor-induced biochemical abnormalities by insulin treatment in rats. J. Natl. Cancer Inst. 77:1986;497-503.
47. Chance W.T., Cao L., Foley-Nelson T., Nelson J.L., Fischer J.E. Possible role of ammonia in experimental cancer anorexia. Brain Res. 486:1989;316-324.
48. Chance W.T., Noguchi Y., Hasselgren P.O., Fischer J.E. Differential effects of tumor and parenteral nutrition on jejunal mucosal polyamines. Nutr. Cancer. 23:1995;23-32.
49. Kanzaki L., Fujisawa M., Okuda Y., Okada H., Arakawa S., Kamidono S. Expression and regulation of neuropeptide Y ribonucleic acid in cultured immature rat Leydig and Sertoli cells. Endocrinology. 137:1996;1249-1257.
50. Sheriff S., Chance W.T., Fischer J.E., Balasubramaniam A. Neuropeptide Y treatment and food deprivation increase cyclic AMP response element binding in rat hypothalamus. Mol. Pharmacol. 51:1997;597-604.